Hong Kong na Phnom Penh, Cambodia, June 22, 2021 / PRNewswire/ - Ministri Ahụike Cambodia akwadola azụmaahịa nke INDICAID® COVID-19 nnwale antigen ngwa ngwa dịka akụkụ nke mbọ obodo ahụ iji chịkwaa ịwa ahụ na nso nso a na COVID-19. ikpe .
Gọọmentị Cambodia ewepụtala nnwale antigen ngwa ngwa dị ka INDICAID® iji mee nyocha buru ibu na isi obodo Phnom Penh na mpaghara ndị gbara ya gburugburu, na-eji obere oge na ịdị mma nke nsonaazụ ule iji nyere gọọmentị aka ịchọpụta ndị ọrịa COVID-19 ngwa ngwa wee kwụsịlata. mgbasa nke ọrịa.Nnwale ndị a butere usoro njide ka mma, na-ekewa isi obodo ahụ nke ọma na mpaghara uhie, oroma na odo dabere na ọnụọgụ ikpe yana ihe ize ndụ nke mbufe.INDICAID® nwekwara ike ịre ahịa na Phnom Penh.
Ricky Chiu, onye nchoputa na onye isi oche nke PHASE Scientific, kwuru, sị: "Anyị kwenyere na izi ezi, ịdị mfe iji na ego nke ngwa ule anyị ga-eme ka INDICAID® rụọ ọrụ dị mkpa na ọrụ nyocha nke gọọmentị Cambodia na-arụ na mpaghara ahụ.Ọrụ."Onye nrụpụta ọrụ nke ngwa ule INDICAID®."Anyị na-anabata mkpebi gọọmentị Cambodia ma na-atụ anya iji ngwa ngwa ule anyị na-akwado mba ndị agbata obi ya."
Chiu kwuru na ọtụtụ mba anabatala INDICAID® iji luso COVID-19 ọgụ.Na Hong Kong ebe PHASE Scientific dị n'isi ụlọ ọrụ, gọọmentị amatala INDICAID® dịka ngwaahịa ahapụtara maka nleta ụlọ ọgwụ na ebe ndị nọọsụ.Ọ bụ akara kachasị ere n'etiti ngwaahịa ndị yiri ya ma ree ihe karịrị nde abụọ.Ụlọ ọgwụ, ụlọ ọrụ gọọmentị na nkeonwe, ụlọ ahịa, ụlọ oriri na ọṅụṅụ na ụlọ akwụkwọ na-anabata ya nke ọma maka nyocha obodo na nke mba ụwa.
INDICAID® COVID-19 Nnwale Antigen ngwa ngwa bụ immunoassay nke akpọrọ akuku mpụta nke emebere iji chọpụta nke ọma SARS-CoV-2 antigen n'ụdị swab imi.Site n'ịdị mma ngwaahịa a pụrụ ịdabere na ya na ịdị mfe iji, INDICAID® nwere ike ịnye nsonaazụ ngwa ngwa n'ime nkeji 20, na-enweghị mkpa akụrụngwa ma ọ bụ akụrụngwa pụrụ iche.Achọpụtara izi ezi nke ngwa ule a n'ụlọọgwụ n'ime nnwale ụlọ ọgwụ kachasị ukwuu n'ụwa, bụ nke a nwalere INDICAID® megide PCR n'ihe karịrị 9,200 samples wee gosipụta mmetụta dị elu na nkọwapụta.
INDICAID® dị ugbu a na mba 33 ma ọ nọ na usoro ịnweta ikike iji ihe mberede (EUA) site na nchịkwa nri na ọgwụ US (FDA).
Odee: John Vandermosten, CFA TSX: PMN.TO |OTC: ARFXF |NASDAQ: BIIB Otu n'ime ndị na-akpụ akpụ na-agba agba na ngalaba biotechnology bụ akụkọ aducanumab nke mere n'ime afọ ole na ole gara aga.Aducanumab, nke nwere akara ụghalaahịa Aduhelm, bụ ọgwụ mgbochi monoclonal nke amyloid na-eduzi maka ọgwụgwọ ọrịa Alzheimer (AD).Aduhelm na-ejikọta na mkpokọta amyloid ma nwee
Ụlọ ọrụ onwe Cantex Pharmaceuticals Inc abịanyela aka na vTv Therapeutics Inc (NASDAQ: VTVT) nkwekọrịta ikike ịzụlite na ịzụ ahịa azeliragon vTv.Dị ka usoro nke nkwekọrịta ahụ si dị, Cantex ga-ahụ maka mmepe na ịzụ ahịa nke azeliragon, ụlọ ọrụ abụọ ahụ ga-ekesa uru ala n'okpuru nhazi nhazi.Enweghị nkọwa gbasara ego ọzọ ekpughere."Ya mere, enwere ohere ịmepụta azeliragon, usoro nchịkwa ọnụ nke 2
Azụmahịa ezinụlọ na-adịgide adịgide gụnyere isi ihe ịga nke ọma anọ na-akwalite njikọ ezinụlọ, uto azụmahịa na nchekwa akụ na ụba ogologo oge.
Odee: Dr. David Bautz Nasdaq: MNOV Gụọ akụkọ nyocha MNOV zuru ezu Mmelite azụmahịa MN-166 Phase 2 nti nsonaazụ nke nnwale dollar Australia June 21, 2021, MediciNova, Inc. (NASDAQ: MNOV) Na-ekwupụta nsonaazụ dị mma nke Oge 2. Ebipụtara nnwale nke MN-166 (Ibudilast) na nsogbu ịṅụ mmanya na-aba n'anya (AUD) na mbipụta Nature Translational Psychiatry (Grodin et al., 2021).Ọnwụnwa bụ a
Ụwa anabatala ọgwụ mgbochi influenza na arụmọrụ nke na-erughị 50%, ya mere ngwaahịa ndị ka mma nwere ike imegharị ahịa ahụ ma nwee ike gbasaa ahịa.
(Bloomberg) - Ndị ọrụ ahụike New Zealand na-agba mbọ ịchọpụta kọntaktị onye njem Australia si Sydney onye gara Wellington na ngwụsị izu ma bute ọrịa Covid-19.N'ihi na mmegharị a nwere ike ime ka ndị na-ahazi asọmpi Tokyo hapụ atụmatụ ire mmanya na-aba n'anya n'ebe a na-eme egwuregwu, Kyodo News kọrọ na o nyere aka na mgbasa nke nje a, mana enweghị ikike.Dị ka ndị isi na-enwe nchegbu banyere mpụta nke ụdị ọhụrụ, China na-ezube idobe mgbochi njem ma ọ dịkarịa ala afọ ọzọ.Ndị White House kwetara
Banye ọkwa ọhụrụ 10 nke ndụ, cheta na ị ga-etinye ụkwụ na nchebe mmetụta uche maka atụmatụ nke gị.www.vhis.gov.hk Lelee ya!
Mgbe ọtụtụ ntiwapụ nke Coronavirus gburugburu ụlọ akwụkwọ ahụ, Israel na-atụ aro ịgba ọgwụ mgbochi ndị na-eto eto, ọbụlagodi ndị gbara ọgwụ mgbochi zuru oke nwere ike bute nje a n'ihi na ndị ọchịchị na-ata ụta Delta dị iche iche na-efe efe.Mba a gosipụtara ikpe ọhụrụ 125 n'ime awa 24 na Tuesday, ngụkọta otu ụbọchị kachasị elu kemgbe njedebe nke Eprel.Mgbe nnwale na-enweghị usoro, ahụrụ ntiwapụ kachasị ọhụrụ n'ọtụtụ ụlọ akwụkwọ, na mgbe Israel buliri ihe fọrọ nke nta ka ọ bụrụ ihe mgbochi coronavirus niile
Nwa nwanyị nke onye ọrụ mpaghara a na-agbaghị ọgwụ mgbochi na Florida nwụrụ mgbe COVID-19 gachara n'ụlọ ọrụ gọọmentị ebe ọ na-arụ ọrụ.O kwuru na ya na ezinụlọ ya ekweghị ka a gbaa ya ọgwụ, n’agbanyeghị na onye ọrụ ibe nne ha bụ́ onye e gbanyere ọgwụ ahụ adịghị arịa ọrịa ma ọlị.Ọ dịghị onye n'ime ezinụlọ m a na-agba ọgwụ mgbochi, "Molly Hart gwara Daily Beast.Nne Hart, Mary Knight, 58, nwụrụ n'ihi nsogbu metụtara COVID-19 n'izu gara aga, Manatee County Identity Verification.
Na usoro 2/3 ọmụmụ nke Ụlọ Akwụkwọ Ọgwụ nke Mahadum Washington na-eduzi, nnwale mgbochi amyloid nke Eli Lilly na Company (NYSE: LLY) na Roche Holdings (OTC: RHHBY) emeghị ka Al Symptoms of Zheimer's disease (AD) ).afọ.Ugbu a, ndị nchọpụta na-ekwu na ha nwere ihe akaebe na Roche's gantenerumab nwere ike inyere ụfọdụ ndị ọrịa aka.N'ime ndị sonyere na nnwale na Ọrịa Alzheimer Dominant (DIAD), Roche's
Mbelata micro-plan No.1: Nhọrọ 5 dị ọnụ ala [$0 ruo $75000], yana mkpuchi ahụike ụlọ ọrụ iji mebie mkpuchi ahụ iji nweta nchekwa kwa afọ nke nde 30.
Hospitallọ Ọgwụ General Juu (JGH) bụ ụlọ ọrụ ndị otu Montreal Midwestern Health Service (CIUSSS) ma bụrụ onye mbụ sonyere Auger Groupe Conseil Inc. (AGC) na Medtronic Canada ULC (onye enyemaka nke Medtronic (NYSE: MDT)) Jiri Microsoft. HoloLens maka ezigbo oge, agbatịkwu eziokwu (XR) nkwado ụlọ ọgwụ maka ịwa ahụ obi na-efe efe pere mpe.
Dr. Susannah Hills, onye dọkịta na-awa maka ụgbọ elu ụmụaka na onye enyemaka Prọfesọ nke Otolaryngology na Mahadum Ahụike Mahadum Columbia, sonyeere Yahoo Finance iji kparịta akụkọ kachasị ọhụrụ banyere ọrịa ọrịa coronavirus.
Mgbe ndị nchọpụta lere anya n'omume wii wii nke otu ndị nọ n'agbata afọ 18 na 30, nchọpụta ọzọ afọ 25 gachara gafere n'igwe ojii.
Ihe onyonyo nke Pixaby Biotechnology nyere bụ isi mmalite nke ụfọdụ nchọpụta ahụike kachasị mkpa n'ụwa n'afọ ndị na-adịbeghị anya.Ọtụtụ n'ime ọganihu kacha nwee ọganihu, gụnyere ọgwụ mgbochi COVID-19, teknụzụ na-ahụ maka ọrịa na-efe efe, na ụlọ akụ biobank, sitere na mmalite na obere ụlọ ọrụ.Enwere puku kwuru puku mmalite dị otú ahụ na ngalaba biotechnology.Mmụọ ịsụ ụzọ ha na ngbanwe ngwa ngwa na-etinye ụlọ ọrụ ndị a n'ọkwá dị elu na ụlọ ọrụ biomedical.Lee ụfọdụ
Mongolia kwere ndị ya nkwa “okpomọkụ na-enweghị Covid-19”.Bahrain kwuru na ọ "ga-alaghachi na ndụ nkịtị."Obere obodo Seychelles nwere ebumnuche ịmalite akụ na ụba ya.Ha atọ kwenyere ma ọ dịkarịa ala ruo n'ókè ụfọdụ na ọgwụ mgbochi dị mfe dị na China, nke ga-enyere ha aka ịmalite mmemme ịgba ọgwụ mgbochi ọrịa mgbe ha na-adịghị n'ọtụtụ akụkụ ụwa.Agbanyeghị, mba atọ a na-alụ ọgụ ugbu a n'ọrịa na-efe efe kama iwepụ coronavirus.edebanye aha
UniQure NV (NASDAQ: QURE) kwuputara data izu 52 nke etranacogene dezaparvovec maka ọgwụgwọ hemophilia B na usoro ọgwụgwọ usoro ọgwụgwọ HOPE-B nke 3.Data na-egosi na izu 52 mgbe ọgwụgwọ hemophilia B gasịrị, ọrụ nke IX (FIX) nọgidere na-abawanye.N'ime nyocha nke izu 26, nkezi ọrụ FIX etinyere bụ 41.5% nke uru nkịtị, yana nkezi ọrụ FIX bụ 39% nke uru nkịtị.FIX bụ protein a na-emepụta n'ime ahụ, nke na-enyere ọbara aka ịmepụta mkpụkọ iji kwụsị ọbara ọgbụgba.N'ime izu iri ise na abụọ a, otu otu
"ozi ọma: Ọgwụ mgbochi anyị dị irè megide ụdị Delta," Fauci kwukwara."Ọdịiche a na-anọchite anya mmụgharị nke nwere ike ibute mmụkọ na-ezere ọgwụ mgbochi anyị n'ọdịnihu.Nke a bụ ihe mere ịgba ọgwụ mgbochi ọrịa ji dị irè ugbu a karịa ka ọ dị na mbụ.Oge dị mkpa karịa iji kwụsị usoro nke ọrịa-usoro mgbanwe nke nwere ike ibute mmụkọ dị ize ndụ karị, "Rochelle Walensky, onye isi ụlọ ọrụ erslọ Ọrụ Maka Nchịkwa na Mgbochi Ọrịa (CDC) kwuru.Ọdịiche Delta kpatara ajọ ntiwapụ COVID-19 na India n'April na Mee, na-akarị ọrụ ahụike obodo ahụ wee bute ọtụtụ narị puku mmadụ.
Ụlọ ọrụ biotechnology nke German bụ BioNTech SE (BNTX) kpughere na n'ime ule Phase II nke ọgwụ mgbochi ọrịa cancer BNT111 maka melanoma dị elu, a na-enye onye ọrịa mbụ ọgwụ ahụ.BioNTech bụ ọsụ ụzọ na immunotherapy maka ọrịa kansa, ọrịa na-efe efe na ọrịa ndị ọzọ na-adịghị ala ala.Ụlọ ọrụ ahụ nwere nnukwu Pọtụfoliyo nke ndị na-achọ ọgwụgwọ tumor, ọgwụgwọ nnọchi protein, obere immunomodulators molecule, ọgwụ mgbochi ọhụrụ na ọgwụgwọ cell.Akụkụ nke abụọ nke nnwale a na-amụ arụmọrụ nke nchịkwa BNT111
Nnyocha ọhụrụ e bipụtara na JAMA chọpụtara na ụmụ nwoke 45 natara ọgwụ mgbochi COVID-19 mRNA enweghị ọdịiche na oke sperm.Ọgwụ mgbochi mRNA abụọ enyere ikike nke Pfizer na Moderna mepụtara bụ ọgwụ COVID-19 a na-ejikarị na United States.Ndị na-eme nchọpụta na Miller School of Medicine na Mahadum Miami kwuru na ha malitere ọmụmụ ihe ahụ mgbe ha nụchara ihe na-echegbu ụfọdụ ndị..Ekwenyere na ọgwụ mgbochi ọrịa nwere ike imetụta ọmụmụ.Ha rụtụrụ aka na ọmụmụ ihe a nwere oke ụfọdụ
Atai Life Sciences (NASDAQ: ATAI) mere mpụta mbụ ya na NASDAQ na Fraịde.Ụlọ ọrụ Berlin ga-esonye na otu mmalite mmalite na ụlọ ọrụ psychedelic ma depụta ya na NASDAQ n'afọ a, gụnyere MindMed (NASDAQ: MNMD) na Compass Pathways (NASDAQ) Code: CMPS).Site na nkwado nke Peter Thiel, onye nchoputa PayPal (NASDAQ: PYPL), ụlọ ọrụ ahụ ewepụtala ihe karịrị $ 362 nde ego kemgbe e guzobere ya na 2018. Atai welitere $ 225 ọzọ na onyinye ọha na eze mbụ ya na Thursday.
Dr. Ron Friedman, onye ọkà n'akparamàgwà mmadụ na onye dere akwụkwọ "Decoding the Great," gwara Yahoo Finance Live na mgbanwe ndị ọrịa COVID-19 wetara ga-akpalite "mgbanwe n'ụzọ òtù dị iche iche si arụ ọrụ."
Oge nzipu: Jun-23-2021